Swedish Orphan Biovitrum Balance Sheet Health
Financial Health criteria checks 2/6
Swedish Orphan Biovitrum has a total shareholder equity of SEK35.9B and total debt of SEK18.9B, which brings its debt-to-equity ratio to 52.6%. Its total assets and total liabilities are SEK74.5B and SEK38.6B respectively. Swedish Orphan Biovitrum's EBIT is SEK4.6B making its interest coverage ratio 3.7. It has cash and short-term investments of SEK527.0M.
Key information
52.6%
Debt to equity ratio
kr18.90b
Debt
Interest coverage ratio | 3.7x |
Cash | kr527.00m |
Equity | kr35.90b |
Total liabilities | kr38.62b |
Total assets | kr74.52b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B6E's short term assets (SEK12.1B) do not cover its short term liabilities (SEK17.1B).
Long Term Liabilities: B6E's short term assets (SEK12.1B) do not cover its long term liabilities (SEK21.5B).
Debt to Equity History and Analysis
Debt Level: B6E's net debt to equity ratio (51.2%) is considered high.
Reducing Debt: B6E's debt to equity ratio has increased from 41.5% to 52.6% over the past 5 years.
Debt Coverage: B6E's debt is well covered by operating cash flow (25.1%).
Interest Coverage: B6E's interest payments on its debt are well covered by EBIT (3.7x coverage).